Aratana Therapeutics, Inc.

NASDAQ: PETXHealthcare / Biotechnology / USA
4.9500.00Vol 459 4401Y Perf 0.40%
Jun 20th, 2019 16:00
BID4.92 ASK4.98
Open4.94 Previous Close4.95
Pre-Market- After-Trading4.95
 - -%  - -%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potencial %
1.01 
Finscreener Ranking
★★★+ —    -
Insiders Trans % 3/6/12M
-/-/-100 
Value Ranking
★★ —    -
Insiders Value % 3/6/12M
-/-/-100 
Growth Ranking
     34.98
Insiders Shares Cnt. % 3/6/12M
-/-/-100 
Income Ranking
 —    -
Market Cap (mil)242 
Earnings Rating
Buy
Price Range Ratio 52wk %
42.75 
Earnings Date
1st Aug 2019

Today's Price Range

4.935.04

52wk Range

3.307.16

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
2.06%
3 Months
23.75%
6 Months
-13.16%
1 Year
0.40%
3 Years
-19.38%
5 Years
-67.33%

Name / TickerPriceChg.Chg.%
PETX4.950.00000.00
AAPL199.461.59000.80
GOOG1 111.429.09000.82
MSFT136.951.26000.93
XOM76.611.29001.71
WFC45.860.21000.46
JNJ142.211.76001.25
FB189.532.05001.09
GE10.630.29002.80
JPM110.190.28000.25
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.10-0.14-40.00
Q04 2018-0.11-0.18-63.64
Q03 2018-0.130.19246.15
Q02 2018-0.19-0.1426.32
Q01 2018-0.18-0.19-5.56
Q04 2017-0.23-0.1917.39
Q03 2017-0.26-0.2119.23
Q02 2017-0.29-0.2610.34
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.0811.11Positive
9/2019 QR-0.0614.29Positive
12/2019 FY-0.313.13Positive
12/2020 FY0.138.33Positive
Next Report Date1st Aug 2019
Estimated EPS Next Report-0.08
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume459 440
Shares Outstanding (in ths.)48 969
Trades Count1 913
Dollar Volume2 104 487
Avg. Volume815 582
Avg. Weekly Volume365 438
Avg. Monthly Volume403 465
Avg. Quarterly Volume926 862
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
3 (100.00 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Moderate Buy
2.33

Aratana Therapeutics, Inc.

Aratana Therapeutics Inc is a pet therapeutics company. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals. The company's portfolio consists of therapeutic candidates such as small-molecule pharmaceuticals and large-molecule biologics. The main product candidates in development comprise small-molecule pharmaceuticals directed at treating osteoarthritis pain, inflammation, appetite stimulation, and post-operative pain. The firm's strategy consists of licensing proprietary technology from human biopharmaceutical companies or academia to develop therapeutics specifically for use in pets.

CEO: Craig A. Tooman

Teplephone: +1 913 353-1000

Address: 11400 Tomahawk Creek Parkway, Leawood 66211, KS, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

60%40%

News